INS and COVID-19: A recent review of hyperglycemic drugs’ usage concluded that early administration of insulin might have a protective effect against COVID-19 and attenuate lung injury (Nakhleh and Shehadeh 2020) if there is a possibility to reduce insulin resistance in patients.